Learn how transcatheter therapy can benefit patients that would not normally be candidates for TAVR and the importance of including the whole heart team for optimal success.

In this webcast, experts discuss the SURTAVI trial and the SAPIEN 3 study in intermediate-risk patients as well as the outcomes of TAVR and SAVR.